Open access
Oct 2026
Correction: Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
[This corrects the article DOI: 10.3389/fphar.2023.1187066.].
B. Rajamani, R. Illangeswaran, E. Benjamin et al.
· Frontiers in Pharmacology · 0 citations